Neurocardiogenic syncope pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 21: Line 21:
:*On the other end of the spectrum is the vasodepressor response, caused by a [[hypotension|drop in blood pressure]] without much change in [[heart rate]]. This phenomenon occurs due to '''''vasodilation''''' secondary to the withdrawal of [[sympathetic nervous system|sympathetic nervous system tone]].
:*On the other end of the spectrum is the vasodepressor response, caused by a [[hypotension|drop in blood pressure]] without much change in [[heart rate]]. This phenomenon occurs due to '''''vasodilation''''' secondary to the withdrawal of [[sympathetic nervous system|sympathetic nervous system tone]].


As a result of increased [[vagal tone]] and [[vasodilation]], subsequent decrease in [[venous return]] and [[cardiac output]] is observed which is significant enough to cause [[syncope]] or [[loss of consciousness]].
As a result of increased [[vagal tone]] and [[vasodilation]], subsequent decrease in [[venous return]] and [[cardiac output]] is observed which is significant enough to cause [[syncope]] or [[loss of consciousness]].<ref name="pmid10678294">{{cite journal |author=White CM, Tsikouris JP |title=A review of pathophysiology and therapy of patients with vasovagal syncope |journal=[[Pharmacotherapy]] |volume=20 |issue=2 |pages=158–65 |year=2000 |month=February |pmid=10678294 |doi= |url=http://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0277-0008&date=2000&volume=20&issue=2&spage=158 |accessdate=2012-05-17}}</ref><ref>Zaqqa M, Massumi A. Neurally mediated syncope. Tex Heart Institute J 2000;27: 268-72.</ref>


==References==
==References==

Revision as of 12:14, 17 May 2012

Neurocardiogenic Syncope Microchapters

Home

Patient Info

Overview

Pathophysiology

Epidemiology and Demographics

Risk Factors

Causes

Natural History, Complications & Prognosis

Differentiating Neurocardiogenic Syncope From Other Diseases

Diagnosis

History & Symptoms

Physical Examination

Tilt Table Testing

Treatment

Pharmacotherapy

Pacemaker therapy

Neurocardiogenic syncope pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurocardiogenic syncope pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurocardiogenic syncope pathophysiology

CDC on Neurocardiogenic syncope pathophysiology

Neurocardiogenic syncope pathophysiology in the news

Blogs on Neurocardiogenic syncope pathophysiology

Directions to Hospitals Treating Neurocardiogenic Syncope

Risk calculators and risk factors for Neurocardiogenic syncope pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]

Overview

Neurocardiogenic syncope is defined as a syndrome in which triggering of a neural reflex results in a usually self-limited episode of systemic hypotension characterized by both bradycardia (asystole or relative bradycardia) and peripheral vasodilation.

It is caused by an abnormal or exaggerated autonomic response to various stimuli, commonly standing and emotion.[1][2] The underlying mechanism for this exaggerate autonomic response remains unclear; however, the activation of cardiac C fibres has shown to play role which subsequently causes reflex-mediated changes in the vascular tone and heart rate.[3]

On the contrary, failure of autonomic reflex response results in orthostatic hypotension.

Pathophysiology

The underlying mechanism of exaggerated autonomic response to various stimuli in patients with neurocardiogenic stimuli remains unclear. However, the activation of cardiac C-fibres has been implicated in the pathogenesis of neurocardiogenic syncope.[4]

Regardless of the triggers, the mechanism of syncope is similar among various vasovagal syncope syndromes.

Multiple triggering stimuli activate the nucleus tractus solitarius of the brainstem via the cardiac C fibres, which then results in the simultaneous enhancement of the parasympathetic nervous system (vagal) tone and withdrawal of the sympathetic nervous system tone.[5][3][6]

This results in a spectrum of hemodynamic responses:

  • On one end of the spectrum is the cardioinhibitory response caused by an increased vagal tone that is characterized by bradycardia and consequent hypotension that is significant enough to result in loss of consciousness.

As a result of increased vagal tone and vasodilation, subsequent decrease in venous return and cardiac output is observed which is significant enough to cause syncope or loss of consciousness.[7][8]

References

  1. Krediet CT, van Dijk N, Linzer M, van Lieshout JJ, Wieling W (2002). "Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing". Circulation. 106 (13): 1684–9. PMID 12270863. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  2. Lu CC, Diedrich A, Tung CS, Paranjape SY, Harris PA, Byrne DW, Jordan J, Robertson D (2003). "Water ingestion as prophylaxis against syncope". Circulation. 108 (21): 2660–5. doi:10.1161/01.CIR.0000101966.24899.CB. PMID 14623807. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  3. 3.0 3.1 Kapoor WN (2000). "Syncope". The New England Journal of Medicine. 343 (25): 1856–62. doi:10.1056/NEJM200012213432507. PMID 11117979. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  4. Fogoros RN. Practical cardiac diagnosis: electrophysiologic testing. 3 rd ed. Malden, MA: Blackwell Publishing, 1999
  5. Fogoros RN. Practical cardiac diagnosis: electrophysiologic testing. 3 rd ed. Malden, MA: Blackwell Publishing, 1999
  6. Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Moya A, Raviele A, Sutton R, Theodorakis G, Wieling W (2001). "Guidelines on management (diagnosis and treatment) of syncope". European Heart Journal. 22 (15): 1256–306. doi:10.1053/euhj.2001.2739. PMID 11465961. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  7. White CM, Tsikouris JP (2000). "A review of pathophysiology and therapy of patients with vasovagal syncope". Pharmacotherapy. 20 (2): 158–65. PMID 10678294. Retrieved 2012-05-17. Unknown parameter |month= ignored (help)
  8. Zaqqa M, Massumi A. Neurally mediated syncope. Tex Heart Institute J 2000;27: 268-72.

Template:WH Template:WS